Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden)

被引:0
|
作者
Annekatrin Lukanova
Stefan Söderberg
Pär Stattin
Richard Palmqvist
Eva Lundin
Carine Biessy
Sabina Rinaldi
Elio Riboli
Göran Hallmans
Rudolf Kaaks
机构
[1] International Agency for Research on Cancer,Department of Public Health and Clinical Medicine/Nutritional Research
[2] University of Umeå,Department of Nutrition and Cancer
[3] International Agency for Research on Cancer,University of Umeå, Department of Urology and Andrology and the Medical Biobank
[4] Northern Sweden University Hospital,Department of Pathology
[5] University of Umeå,Department of Medical Biosciences/Pathology, and Department of Public Health and Clinical Medicine/Nutritional Research
[6] University of Umeå,undefined
[7] International Agency for Research on Cancer,undefined
来源
Cancer Causes & Control | 2002年 / 13卷
关键词
body mass index; IGF-binding protein-3; IGF-I; insulin; leptin;
D O I
暂无
中图分类号
学科分类号
摘要
Objective: In this study we test the hypothesis of a nonlinear relationship of IGF-I with indices of body fat such as body mass index (BMI), insulin, and leptin. Methods: The controls used in three case–control cancer studies nested in the Northern Sweden Health and Disease Cohort, were combined for this analysis. Measurements of plasma IGF-I, IGFBP-3, insulin, and leptin were available for 445 men and 391 women. Results: In both men and women we found the highest mean IGF-I levels in subjects with BMI between 24 and 26. IGF-I concentrations decreased toward BMI ≤ 20 and BMI > 30 in men; however, the results for women did not reach statistical significance. The molar ratio of IGF-I/IGFBP-3 showed a similar profile to that of IGF-I, although much less pronounced. The observed peak mean IGF-I levels in the second quintiles of insulin and leptin in men supported these findings. No significant variation of mean IGF-I levels across quintiles of insulin and leptin were observed in women. Conclusions: The results of this study provide evidence that IGF-I plasma concentrations vary substantially over a wide range of body weight and that the relationship is nonlinear.
引用
收藏
页码:509 / 516
页数:7
相关论文
共 50 条
  • [1] Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden)
    Lukanova, A
    Söderberg, S
    Stattin, P
    Palmqvist, R
    Lundin, E
    Biessy, C
    Rinaldi, S
    Riboli, E
    Hallmans, G
    Kaaks, R
    CANCER CAUSES & CONTROL, 2002, 13 (06) : 509 - 516
  • [2] Smallness for gestational age is associated with persistent change in insulin-like growth factor I (IGF-I) and the ratio of IGF-I/IGF-binding protein-3 in adulthood
    Verkauskiene, R
    Jaquet, D
    Deghmoun, S
    Chevenne, D
    Czernichow, P
    Lévy-Marchal, C
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (10): : 5672 - 5676
  • [3] Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in benign prostatic hyperplasia and prostate cancer
    Khosravi, J
    Diamandi, A
    Mistry, J
    Scorilas, A
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02): : 694 - 699
  • [4] Serum free insulin-like growth factor I (IGF-I), total IGF-I, and IGF-binding protein-3 concentrations in normal children and children with growth hormone deficiency
    Kawai, N
    Kanzaki, S
    Takano-Watou, S
    Tada, C
    Yamanaka, Y
    Miyata, T
    Oka, M
    Seino, Y
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (01): : 82 - 89
  • [5] ANURAN INSULIN-LIKE GROWTH FACTOR-I (IGF-I) AND IGF-BINDING PROTEIN (IGF-BP)
    PANCAKROESSLER, MK
    LEE, PDK
    AMERICAN ZOOLOGIST, 1988, 28 (04): : A144 - A144
  • [6] Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer
    Krajcik, RA
    Borofsky, ND
    Massardo, S
    Orentreich, N
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (12) : 1566 - 1573
  • [7] REGULATION OF INSULIN-LIKE GROWTH-FACTOR (IGF) BINDING PROTEIN-3 PHOSPHORYLATION BY IGF-I
    COVERLEY, JA
    BAXTER, RC
    ENDOCRINOLOGY, 1995, 136 (12) : 5778 - 5781
  • [8] Serum insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 levels in severe iodine deficiency
    Alikasifoglu, A
    Özön, A
    Yordam, N
    TURKISH JOURNAL OF PEDIATRICS, 2002, 44 (03) : 215 - 218
  • [9] Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density
    Byrne, C
    Colditz, GA
    Willett, WC
    Speizer, FE
    Pollak, M
    Hankinson, SE
    CANCER RESEARCH, 2000, 60 (14) : 3744 - 3748
  • [10] Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 in girls with premature thelarche
    Sales, DS
    Moreira, AC
    Camacho-Hübner, C
    Ricco, RG
    Daneluzzi, JC
    Campos, AD
    Martinelli, CE
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2003, 16 (06): : 827 - 833